As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
NEW YORK (AP) — Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential stocks kept indexes in check. The S&P 500 rose 0.1% ...
We recently compiled a list of the 12 Safest Stocks to Buy According to Hedge Funds. In this article, we are going to take a ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...
MoneywebNOW took a look at whether GLP-1 drugs present a good investment opportunity, future inflation expectations and more.
Opinion
Editorial Roundup: United States
The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, easily outpacing consumption growth and fueling an expor ...
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward ...